WO2008089256A3 - Polymeric therapeutics - Google Patents

Polymeric therapeutics Download PDF

Info

Publication number
WO2008089256A3
WO2008089256A3 PCT/US2008/051193 US2008051193W WO2008089256A3 WO 2008089256 A3 WO2008089256 A3 WO 2008089256A3 US 2008051193 W US2008051193 W US 2008051193W WO 2008089256 A3 WO2008089256 A3 WO 2008089256A3
Authority
WO
WIPO (PCT)
Prior art keywords
polymers
disclosed
covalent bond
chemical moiety
therapeutics
Prior art date
Application number
PCT/US2008/051193
Other languages
French (fr)
Other versions
WO2008089256A2 (en
Inventor
Rachit Ohri
Mark Steckel
Shrirang Ranade
Original Assignee
Cappella, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cappella, Inc. filed Critical Cappella, Inc.
Publication of WO2008089256A2 publication Critical patent/WO2008089256A2/en
Publication of WO2008089256A3 publication Critical patent/WO2008089256A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6957—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a device or a kit, e.g. stents or microdevices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/605—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the macromolecule containing phosphorus in the main chain, e.g. poly-phosphazene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid

Abstract

Disclosed herein are polymers comprising a chemical moiety linked through a covalent bond, where the chemical moiety forms a pharmaceutically active agent upon degradation of the covalent bond. The polymers can be chosen from star polymers, dendrimers, and hyperbranched polymers. Also disclosed are coatings for implantable medical device comprising such polymers.
PCT/US2008/051193 2007-01-16 2008-01-16 Polymeric therapeutics WO2008089256A2 (en)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US88510507P 2007-01-16 2007-01-16
US88510907P 2007-01-16 2007-01-16
US88509707P 2007-01-16 2007-01-16
US88511207P 2007-01-16 2007-01-16
US60/885,109 2007-01-16
US60/885,112 2007-01-16
US60/885,097 2007-01-16
US60/885,105 2007-01-16
US94230107P 2007-06-06 2007-06-06
US94230907P 2007-06-06 2007-06-06
US60/942,309 2007-06-06
US60/942,301 2007-06-06
US94307707P 2007-06-11 2007-06-11
US60/943,077 2007-06-11

Publications (2)

Publication Number Publication Date
WO2008089256A2 WO2008089256A2 (en) 2008-07-24
WO2008089256A3 true WO2008089256A3 (en) 2009-12-30

Family

ID=39540689

Family Applications (3)

Application Number Title Priority Date Filing Date
PCT/US2008/051196 WO2008089258A2 (en) 2007-01-16 2008-01-16 Drug eluting medical device using polymeric therapeutics
PCT/US2008/051193 WO2008089256A2 (en) 2007-01-16 2008-01-16 Polymeric therapeutics
PCT/US2008/051195 WO2008089257A2 (en) 2007-01-16 2008-01-16 Drug eluting medical device using polymeric therapeutics with transglutaminase substrates

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2008/051196 WO2008089258A2 (en) 2007-01-16 2008-01-16 Drug eluting medical device using polymeric therapeutics

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US2008/051195 WO2008089257A2 (en) 2007-01-16 2008-01-16 Drug eluting medical device using polymeric therapeutics with transglutaminase substrates

Country Status (1)

Country Link
WO (3) WO2008089258A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10772993B2 (en) * 2017-02-23 2020-09-15 Medtronic Vascular, Inc. Drug coated medical devices
CN108559086A (en) * 2018-05-21 2018-09-21 武汉工程大学 A kind of vinyl modified star polyphosphate and its synthetic method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030073615A1 (en) * 1996-03-12 2003-04-17 Cell Therapeutics, Inc. Water soluble paclitaxel derivatives
WO2003055935A1 (en) * 2001-12-21 2003-07-10 Board Of Regents - The University Of Texas System Dendritic poly (amino acid) carriers and methods of use
WO2004035629A2 (en) * 2002-10-18 2004-04-29 Fidia Farmaceutici S.P.A. Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328204A (en) * 1977-03-02 1982-05-04 Ethicon, Inc. Absorbable polymer-drug compounds and method for making same
GB0011356D0 (en) * 2000-05-12 2000-06-28 Univ Nottingham Trent Medical implant materials
US7169404B2 (en) * 2003-07-30 2007-01-30 Advanced Cardiovasular Systems, Inc. Biologically absorbable coatings for implantable devices and methods for fabricating the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030073615A1 (en) * 1996-03-12 2003-04-17 Cell Therapeutics, Inc. Water soluble paclitaxel derivatives
WO2003055935A1 (en) * 2001-12-21 2003-07-10 Board Of Regents - The University Of Texas System Dendritic poly (amino acid) carriers and methods of use
WO2004035629A2 (en) * 2002-10-18 2004-04-29 Fidia Farmaceutici S.P.A. Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ACHARYA G ET AL: "Mechanisms of controlled drug release from drug-eluting stents", ADVANCED DRUG DELIVERY REVIEWS 20060603 NL, vol. 58, no. 3, 3 June 2006 (2006-06-03), pages 387 - 401, XP002533859, ISSN: 0169-409X *
COMMANDEUR S ET AL: "Polymers, drug release, and drug-eluting stents", JOURNAL OF INTERVENTIONAL CARDIOLOGY 200612 US, vol. 19, no. 6, December 2006 (2006-12-01), pages 500 - 506, XP002533860, ISSN: 0896-4327 1540-8183 *

Also Published As

Publication number Publication date
WO2008089258A3 (en) 2009-12-30
WO2008089256A2 (en) 2008-07-24
WO2008089258A2 (en) 2008-07-24
WO2008089257A3 (en) 2009-12-23
WO2008089257A2 (en) 2008-07-24

Similar Documents

Publication Publication Date Title
WO2006049907A3 (en) Implantable devices comprising biologically absorbable star polymers
WO2009141823A3 (en) Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases
WO2012040623A3 (en) Nanostructured gels capable of controlled release of encapsulated agents
WO2007133924A3 (en) Biodegradable modified caprolactone polymers for fabricating and coating medical devices
WO2009140421A8 (en) Polymeric carrier
WO2006031965A3 (en) Controlled release antimicrobial polymer compositions
WO2007092583A3 (en) Functionalizing implantable devices with a poly (diol-co-citrate) polymer
WO2007147010A3 (en) Implantable medical devices and methods for making the same
WO2007030266A3 (en) Nitric oxide-releasing polymers derived from modified polyimines
WO2008141110A3 (en) Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs
WO2010091192A3 (en) Nanoscale platinum compounds and methods of use thereof
WO2008140482A3 (en) Medical devices having coatings for controlled therapeutic agent delivery
WO2007146426A3 (en) Nanoshells for drug delivery
WO2009099768A3 (en) Biodegradable coatings for implantable medical devices
WO2006107903A3 (en) Polymeric micelles for drug delivery
WO2008076333A3 (en) Polymer-drug conjugates with tether groups for controlled drug delivery
WO2006074391A3 (en) Biodegradable coating compositions comprising blends
WO2006023672A3 (en) Biologically absorbable polymers for implantable devices having a constant rate of degradation
WO2007148230A3 (en) Grafted polymers and uses thereof
WO2006074406A3 (en) Biodegradable coating compositions including multiple layers
WO2007024481A3 (en) 4-aza-caprolactone-based polymeric compositions useful for the manufacture of biodegradable medical devices and as medical device coatings
WO2009014827A3 (en) Medical devices comprising polymeric drug delivery systems with drug solubility gradients
WO2008137237A3 (en) Method for forming crystallized therapeutic agents on a medical device
WO2008141111A3 (en) Polymers conjugated with platinum drugs
WO2008121348A8 (en) Peripheral opioid receptor antagonists and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08727751

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08727751

Country of ref document: EP

Kind code of ref document: A2